Men | 22 (85%) | 18 (75%) | NS |
Age (years) | 62 (12) | 60 (12) | NS |
Previous MI | 24 (92%) | 24 (100%) | NS |
Q wave MI | 20 (83%) | 21 (87)% | NS |
Anterior MI | 14 (54%) | 15 (62%) | NS |
NYHA class | 3.15 (0.8) | 2.96 (0.7) | NS |
CCS class | 2.57 (0.7) | 2.67 (0.6) | NS |
Stenotic vessels | 2.4 (0.7) | 2.7 (0.6) | NS |
Smoking | 12 (46%) | 14 (58%) | NS |
Hypertension | 22 (85%) | 21 (87%) | NS |
Hypercholesterolaemia | 16 (61%) | 13 (54%) | NS |
Family history of CAD | 13 (50%) | 16 (67%) | NS |
Diabetes mellitus | 1 (5%) | 2 (8%) | NS |
Lipid lowering drugs | 13 (50%) | 10 (42%) | NS |
ACE inhibitors | 17 (65%) | 19 (79%) | NS |
Nitrates | 22 (85%) | 19 (79%) | NS |
β Blockers | 16 (61%) | 16 (67%) | NS |
Diuretics | 12 (46%) | 16 (67%) | NS |
Digoxin | 4 (15%) | 7 (29%) | NS |
Aspirin/anticoagulant | 26 (100%) | 22 (92%) | NS |
LVEF (%)* | 33 (10) | 32 (7) | NS |
LV end diastolic volume (ml) | 160 (59) | 194 (39) | <0.05 |
LV end systolic volume (ml) | 105 (49) | 135 (37) | <0.05 |
LV sphericity index† | 0.58 (0.09) | 0.61 (0.11) | NS |